• Nachrichtendetail
• 

18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	MERCK CO. DL-,01	A0YD8Q	Frankfurt	118,000	11.07.24 17:39:21	+0,600	+0,51%	117,600	117,800	116,800	117,400
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	88,500	11.07.24 08:21:16	+4,000	+4,73%	90,000	91,000	88,500	84,500